The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Liver fibrosis results from dysregulation of normal wound healing, inflammation, activation of myofibroblasts, and deposition of extracellular matrix (ECM). Chronic liver injury causes death of hepatocytes and formation of apoptotic bodies, which in turn, release factors that recruit inflammatory cells (neutrophils, monocytes, macrophages, and lymphocytes) to the injured liver. Hepatic macrophages (Kupffer cells) produce TGFβ1 and other inflammatory cytokines that activate Collagen Type I producing myofibroblasts, which are not present in the normal liver. Secretion of TGFβ1 and activation of myofibroblasts play a critical role in the pathogenesis of liver fibrosis of different etiologies. Although the composition of fibrogenic myofibroblasts varies dependent on etiology of liver injury, liver resident hepatic stellate cells and portal fibroblasts are the major source of myofibroblasts in fibrotic liver in both experimental models of liver fibrosis and in patients with liver disease. Several studies have demonstrated that hepatic fibrosis can reverse upon cessation of liver injury. Regression of liver fibrosis is accompanied by the disappearance of fibrogenic myofibroblasts followed by resorption of the fibrous scar. Myofibroblasts either apoptose or inactivate into a quiescent-like state (e.g., stop collagen production and partially restore expression of lipogenic genes). Resolution of liver fibrosis is associated with recruitment of macrophages that secrete matrix-degrading enzymes (matrix metalloproteinase, collagenases) and are responsible for fibrosis resolution. However, prolonged/repeated liver injury may cause irreversible crosslinking of ECM and formation of uncleavable collagen fibers. Advanced fibrosis progresses to cirrhosis and hepatocellular carcinoma. The current review will summarize the role and contribution of different cell types to populations of fibrogenic myofibroblasts in fibrotic liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Thus, primarily activation of HSCs with upregulation of α-SMA is observed in patients with viral hepatitis B and C (Giannelli and Antonaci, 2005; Friedman, 2008a,b).”
BackgroundChIP–seq: advantages and challenges of a maturing technology
Park, P. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2641 · Cited by 2,217 · cited 2×
“Post-translational modifications of the core histone subunits of nucleosomes are a fundamental mechanism by which the transcriptional activity of an associated gene locus can be regulated by methylation, acetylation, and phosphorylation (Henikoff, 2008; Park, 2009; Heinz and Glass, 2012).”
BackgroundMethodSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · cited 3×
“The current review will summarize the role and contribution of different cell types to populations of fibrogenic myofibroblasts in fibrotic liver.”
BackgroundMichalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 2×
“…of the etiological source of the chronic injury, regression of liver fibrosis is associated with decreased cytokines and ECM production, increased collagenase activity, disappearance of myofibroblast population and dissolution of the fibrous scar (Iredale et al., 1998; Bataller and Brenner, 2005).”
BackgroundPeripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
Abe, R., Donnelly, S. C., Peng, T., Bucala, R., & Metz, C. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7556 · Cited by 967 · cited 2×
“Bone marrow derived collagen producing Fibrocytes Fibrocytes were first described by Bucala et al. (1994), Bucala (2008), and Grieb et al. (2011) and are defined by the simultaneous expression of CD45 and collagen type I. Fibrocytes possess dual characteristics of fibroblasts (expression of collagen type I, fibronecti…”
BackgroundCatapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Yousefi, S., Gold, J. A., Andina, N., Lee, J. J., Kelly, A. M., Kozlowski, E., Schmid, I., Straumann, A., Reichenbach, J., Gleich, G. J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1855 · Cited by 967 · cited 1×
“…entrapment of bacteria in extracellular DNA-based structures (“DNA traps”; Kisseleva et al., 2011), a mechanism previously identified only in neutrophils, eosinophils, mast cells, and macrophages (Brinkmann et al., 2004; von Kockritz-Blickwede et al., 2008; Yousefi et al., 2008; Chow et al., 2010).”
BackgroundBeneficial suicide: why neutrophils die to make NETs
Brinkmann, V., & Zychlinsky, A. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1710 · Cited by 937 · cited 1×
“Although the antimicrobial properties of fibrocytes are aimed at stopping infection (Brinkmann and Zychlinsky, 2007), release of nuclear DNA and lysosomal peptides into the extracellular space facilitates inflammation, and was shown to cause autoimmune vasculitis (Kessenbrock et al., 2009).”
BackgroundMyofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Self-citationNon-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766 · cited 1×
“…recombination Frontiers in Pharmacology | Inflammation Pharmacology July 2014 | Volume 5 | Article 167 | 2 in HSCs (Kisseleva and Brenner, 2008a; Krizhanovsky et al., 2008; Lujambio et al., 2013), in cholangiocytes (Mederacke et al., 2013), or in both HSCs and cholangiocytes (Yang et al., 2008).”
BackgroundHistory, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells
Geerts, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17550 · Cited by 740
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · cited 2×
“Recent studies have demonstrated that IL-6, leptin, and IL-17A can also trigger HSC activation (Bethanis and Theocharis, 2006; Michalopoulos, 2007; Meng et al., 2012).”
BackgroundSelf-citationDeactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
CCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Mann, J., Chu, D. C. K., Maxwell, A., Oakley, F., Zhu, N., Tsukamoto, H., & Mann, D. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.002 · Cited by 397
Hazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310284200 · Cited by 320 · cited 2×
“Consistently, overexpression of PPARγ in aHSCs/myofibroblasts in vitro results in reversion of HSC activation, and reacquisition of their adipogenic characteristics (Hazra et al., 2004; Jaster et al., 2005).”
BackgroundPortal fibroblasts: Underappreciated mediators of biliary fibrosis†
Dranoff, J. A., & Wells, R. G. (2010) · Hepatology · doi:10.1002/hep.23405 · Cited by 273
Asahina, K., Tsai, S. Y., Li, P., Ishii, M., Maxson, R. E., Sucov, H. M., & Tsukamoto, H. (2009) · Hepatology · doi:10.1002/hep.22721 · Cited by 238 · cited 2×
“HSCs and PFs are the liver resident mesenchymal cells (Asahina et al., 2009), they activate and proliferate in response to injury, and are believed to be the major source of myofibroblasts in fibrotic liver (Bataller and Brenner, 2005; Kisseleva et al., 2006, 2011; Parola et al., 2008; Roderfeld et…”
BackgroundFickert, P., Fuchsbichler, A., Moustafa, T., Wagner, M., Zollner, G., Halilbasic, E., Stöger, U., Arrese, M., Pizarro, M., Solís, N., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090114 · Cited by 169 · cited 3×
“…flippase (Mdr2/Abcb4−/− mice) spontaneously develop liver injury (PSC; Shimamura et al., 2008), (Fichtner-Feigl et al., 2006; Jinnin et al., 2006; Fickert et al., 2009; Baghdasaryan et al., 2010; Mair et al., 2010; McHedlidze et al., 2013), which resembles PSC and most closely mimics MDR3…”
BackgroundTranscriptional regulation of hepatic stellate cells
Mann, J., & Mann, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.011 · Cited by 119
Research works printed but not linked: 146
- Asahina, 2002, Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver., Am. J. Pathol., 160, 2191, 10.1016/S0002-9440(10)61167-4 · DOI
- Asahina, 2011, Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver., Hepatology, 53, 983, 10.1002/hep.24119 · DOI · Paper page
- Baghdasaryan, 2010, Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation., Gut, 59, 521, 10.1136/gut.2009.186528 · DOI
- Balmelli, 2007, Responsiveness of fibrocytes to toll-like receptor danger signals., Immunobiology, 212, 693, 10.1016/j.imbio.2007.09.009 · DOI
- Balmelli, 2005, Fibrocytes are potent stimulators of anti-virus cytotoxic T cells., J. Leukoc. Biol., 77, 923, 10.1189/jlb.1204701 · DOI
- Bataller, 2003, NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis., J. Clin. Invest., 112, 1383, 10.1172/JCI18212 · DOI · Paper page
- Bellini, 2007, The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses., Lab. Invest., 87, 858, 10.1038/labinvest.3700654 · DOI · Paper page
- Berg, 2007, Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation., Hepatology, 46, 1187, 10.1002/hep.21814 · DOI · Paper page
- Bethanis, 2006, Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?, Dig. Dis. Sci., 51, 1685, 10.1007/s10620-006-9126-0 · DOI
- Bhunchet, 1992, Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis., Hepatology, 16, 1452, 10.1002/hep.1840160623 · DOI · Paper page
- Bosselut, 2010, Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts., Proteomics, 10, 1017, 10.1002/pmic.200900257 · DOI · Paper page
- Brenner, 2011, “Contribution of fibrocytes to liver fibrosis: current concept and future prospectives,†in, Fibrocytes in Health and Disease
- Brenner, 2012, Origin of myofibroblasts in liver fibrosis., Fibrogenesis Tissue Repair 5(Suppl., 1, 10.1186/1755-1536-5-S1-S17 · DOI · Paper page
- Brenner, 1989, Analysis of the collagen alpha 1(I). promoter., Nucleic Acids Res., 17, 6055, 10.1093/nar/17.15.6055 · DOI
- Brinkmann, 2004, Neutrophil extracellular traps kill bacteria., Science, 303, 1532, 10.1126/science.1092385 · DOI · Paper page
- Bucala, 2008, Circulating fibrocytes: cellular basis for NSF., J. Am. Coll. Radiol., 5, 36, 10.1016/j.jacr.2007.08.016 · DOI
- Bucala, 1994, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair., Mol Med., 1, 71, 10.1007/BF03403533 · DOI · Paper page
- Cassiman, 2006, Hepatic stellate cells do not derive from the neural crest., J. Hepatol., 44, 1098, 10.1016/j.jhep.2005.09.023 · DOI
- Cassiman, 2002, Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers., J. Hepatol., 36, 200, 10.1016/S0168-8278(01)00260-4 · DOI · Paper page
- Chapman, 2007, Ultrastructural features of Glisson’s capsule and the overlying mesothelium in rat, monkey and pike liver., Tissue Cell, 39, 343, 10.1016/j.tice.2007.06.005 · doi:10.1016/j.tice.2007.06.005
- Chesney, 1997, The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ., Proc. Natl. Acad. Sci. U.S.A., 94, 6307, 10.1073/pnas.94.12.6307 · DOI · Paper page
- Choi, 2009, Epithelial-to-mesenchymal transitions in the liver., Hepatology, 50, 2007, 10.1002/hep.23196 · DOI · Paper page
- Chow, 2010, Statins enhance formation of phagocyte extracellular traps., Cell Host Microbe, 8, 445, 10.1016/j.chom.2010.10.005 · DOI · Paper page
- Chu, 2011, Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis., Hepatology, 53, 1685, 10.1002/hep.24206 · DOI · Paper page
- Clouzeau-Girard, 2006, Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices., Lab. Invest., 86, 275, 10.1038/labinvest.3700386 · DOI
- Cowper, 2003, Nephrogenic fibrosing dermopathy: suspect identified, motive unclear., Am. J. Dermatopathol., 25, 10.1097/00000372-200308000-00017 · DOI
- Curnow, 2010, Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum., PLoS ONE, 5, 10.1371/journal.pone.0009730 · DOI
- De Minicis, 2007, Gene expression profiles during hepatic stellate cell activation in culture and in vivo., Gastroenterology, 132, 1937, 10.1053/j.gastro.2007.02.033 · DOI · Paper page
- Deng, 2011, Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia., Dig. Dis. Sci., 56, 731, 10.1007/s10620-010-1347-6 · DOI
- Desmouliere, 1997, Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat., Lab. Invest., 76, 765
- Dranoff, 2002, The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver., Hepatology, 36, 1135, 10.1053/jhep.2002.36823 · DOI
- Dudas, 2007, Thy-1 is an in vivo and in vitro marker of liver myofibroblasts., Cell Tissue Res., 329, 503, 10.1007/s00441-007-0437-z · DOI
- Ekert, 2011, Chemokine (C-C motif). ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes., Fibrogenesis Tissue Repair, 10.1186/1755-1536-4-23 · DOI
- Enzan, 1994, Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma., Hepatology, 19, 895, 10.1002/hep.1840190415 · DOI · Paper page
- Eyden, 2008, The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine., J. Cell. Mol. Med., 12, 22, 10.1111/j.1582-4934.2007.00213.x · DOI · Paper page
- Fabris, 2011, Epithelial-mesenchymal interactions in biliary diseases., Semin. Liver Dis., 31, 11, 10.1055/s-0031-1272832 · DOI
- Fallowfield, 2007, Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis., J. Immunol., 178, 5288, 10.4049/jimmunol.178.8.5288 · DOI · Paper page
- Fausther, 2011, New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice., J. Hepatol., 55, 939, 10.1016/j.jhep.2011.04.013 · DOI
- Fausther, 2013, Contribution of myofibroblasts of different origins to liver fibrosis., Curr. Pathobiol. Rep., 1, 225, 10.1007/s40139-013-0020-0 · DOI
- Fausther, 2012, Activated hepatic stellate cells upregulate transcription of ecto-5’-nucleotidase/CD73 via specific SP1 and SMAD promoter elements., Am. J. Physiol. Gastrointest. Liver Physiol., 303, G904, 10.1152/ajpgi.00015.2012 · DOI
- Fichtner-Feigl, 2006, IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis., Nat. Med., 12, 99, 10.1038/nm1332 · DOI · Paper page
- Forbes, 2011, Liver fibrogenic cells., Best Pract. Res. Clin. Gastroenterol., 25, 207, 10.1016/j.bpg.2011.02.006 · DOI
- Friedman, 2008b, Mechanisms of hepatic fibrogenesis., Gastroenterology, 134, 1655, 10.1053/j.gastro.2008.03.003 · DOI · Paper page
- Friedman, 1985, Hepatic lipocytes: the principal collagen-producing cells of normal rat liver., Proc. Natl. Acad. Sci. U.S.A., 82, 681, 10.1073/pnas.82.24.8681 · DOI · Paper page
- Gaca, 2003, Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells., Matrix Biol., 22, 229, 10.1016/S0945-053X(03)00017-9 · DOI
- Galan, 2006, Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)., Curr. Opin. Rheumatol., 18, 614, 10.1097/01.bor.0000245725.94887.8d · DOI · Paper page
- Giannelli, 2005, Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection., Histol. Histopathol., 20, 939
- Gilbertson, 2003, Cre-lox recombination: cre-ative tools for plant biotechnology., Trends Biotechnol., 21, 550, 10.1016/j.tibtech.2003.09.011 · DOI
- Goddard, 1998, Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis., Gut, 43, 433, 10.1136/gut.43.3.433 · DOI
- Gomperts, 2007, Fibrocytes in lung disease., J. Leukoc. Biol., 82, 449, 10.1189/jlb.0906587 · DOI · Paper page
- Goodpaster, 2008, An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue., J. Histochem. Cytochem., 56, 347, 10.1369/jhc.7A7287.2007 · DOI · Paper page
- Grieb, 2011, Circulating fibrocytes-biology and mechanisms in wound healing and scar formation., Int. Rev. Cell Mol. Biol., 291, 1, 10.1016/B978-0-12-386035-4.00001-X · DOI
- Hao, 2013, Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo., Clin. Exp. Med., 14, 141, 10.1007/s10238-013-0229-6 · DOI
- Heinz, 2012, Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies., Curr. Top. Microbiol. Immunol., 356, 1, 10.1007/82_2011_142 · DOI
- Henikoff, 2008, Nucleosome destabilization in the epigenetic regulation of gene expression., Nat. Rev. Genet., 9, 15, 10.1038/nrg2206 · DOI · Paper page
- Higashiyama, 2009, Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice., Gastroenterology, 137, 1459, 10.1053/j.gastro.2009.07.006 · DOI
- Hong, 2007, Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma., J. Biol. Chem., 282, 22910, 10.1074/jbc.M703597200 · DOI · Paper page
- Inokuchi, 2011, Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice., Alcohol. Clin. Exp. Res., 35, 1509
- Iredale, 2001, Hepatic stellate cell behavior during resolution of liver injury., Semin. Liver Dis., 21, 427, 10.1055/s-2001-17557 · DOI · Paper page
- Ishida, 2007, Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration., Am. J. Pathol., 170, 843, 10.2353/ajpath.2007.051213 · DOI · Paper page
- Itoh, 2013, Pathophysiological roles of FGF signaling in the heart., Front. Physiol., 4, 10.3389/fphys.2013.00247 · DOI
- Iwaisako, 2012, What’s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis., J. Gastroenterol. Hepatol., 65, 10.1111/j.1440-1746.2011.07002.x · DOI · Paper page
- Jaster, 2005, Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells., J. Cell Mol. Med., 9, 670, 10.1111/j.1582-4934.2005.tb00497.x · DOI
- Jhandier, 2005, Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2., J. Biol. Chem., 280, 22986, 10.1074/jbc.M412371200 · DOI
- Ji, 2012, Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response., Hepatology, 56, 332, 10.1002/hep.25650 · DOI · Paper page
- Jinnin, 2006, Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways., J. Invest. Dermatol., 126, 551, 10.1038/sj.jid.5700090 · DOI
- Kallis, 2009, The bone marrow and liver fibrosis: friend or foe?, Gastroenterology, 137, 1218, 10.1053/j.gastro.2009.08.026 · DOI · Paper page
- Kalluri, 2009, EMT: when epithelial cells decide to become mesenchymal-like cells., J. Clin. Invest., 119, 1417, 10.1172/JCI39675 · DOI · Paper page
- Kalluri, 2003, Epithelial-mesenchymal transition and its implications for fibrosis., J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI · Paper page
- Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis., Nat. Med., 15, 623, 10.1038/nm.1959 · DOI · Paper page
- Kisseleva, 2006, Hepatic stellate cells and the reversal of fibrosis., J. Gastroenterol. Hepatol., S84, 10.1111/j.1440-1746.2006.04584.x · DOI · Paper page
- Kisseleva, 2007, Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis., J. Gastroenterol. Hepatol., S73, 10.1111/j.1440-1746.2006.04658.x · DOI · Paper page
- Kisseleva, 2008a, Fibrogenesis of parenchymal organs., Proc. Am. Thorac. Soc., 5, 338, 10.1513/pats.200711-168DR · DOI · Paper page
- Kisseleva, 2008b, Mechanisms of fibrogenesis., Exp. Biol. Med., 233, 109, 10.3181/0707-MR-190 · DOI · Paper page
- Kisseleva, 2011, Anti-fibrogenic strategies and the regression of fibrosis., Best Pract. Res. Clin. Gastroenterol., 25, 305, 10.1016/j.bpg.2011.02.011 · DOI · Paper page
- Kisseleva, 2012, The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis., J. Hepatol., 56, 965, 10.1016/j.jhep.2011.09.021 · DOI · Paper page
- Kisseleva, 2006, Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis., J. Hepatol., 45, 429, 10.1016/j.jhep.2006.04.014 · DOI · Paper page
- Kisseleva, 2011, Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection., J. Mol. Med., 89, 997, 10.1007/s00109-011-0756-0 · DOI · Paper page
- Kleaveland, 2014, Paracrine functions of fibrocytes to promote lung fibrosis., Expert. Rev. Respir. Med., 8, 163, 10.1586/17476348.2014.862154 · DOI
- Knittel, 1999, Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential., Gastroenterology, 117, 1205, 10.1016/S0016-5085(99)70407-5 · DOI · Paper page
- Kruglov, 2002, Isolation of primary rat liver fibroblasts., J. Investig. Med., 50, 179, 10.2310/6650.2002.33431 · DOI · Paper page
- Lemoinne, 2013, Origins and functions of liver myofibroblasts., Biochim. Biophys. Acta, 1832, 948, 10.1016/j.bbadis.2013.02.019 · DOI
- Li, 2007, Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture., Hepatology, 46, 1246, 10.1002/hep.21792 · DOI · Paper page
- Lin, 2008, Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney., Am. J. Pathol., 173, 1617, 10.2353/ajpath.2008.080433 · DOI · Paper page
- Liu, 2003, Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent., J. Biol. Chem., 278, 11721, 10.1074/jbc.M207728200 · DOI · Paper page
- Liu, 2013, Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts., Curr. Pathobiol. Rep., 1, 209, 10.1007/s40139-013-0018-7 · DOI
- Magness, 1999, Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion., Biochim. Biophys. Acta, 1453, 161, 10.1016/S0925-4439(98)00096-9 · DOI
- Magness, 2004, A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations., Hepatology, 40, 1151, 10.1002/hep.20427 · DOI · Paper page
- Mair, 2010, Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis., Gastroenterology, 138, 2499, 10.1053/j.gastro.2010.02.049 · DOI
- Meurer, 2013, Overexpression of endoglin modulates TGF-beta1-signalling pathways in a novel immortalized mouse hepatic stellate cell line., PLoS ONE, 8, 10.1371/journal.pone.0056116 · DOI
- Moore, 2005, CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury., Am. J. Pathol., 166, 675, 10.1016/S0002-9440(10)62289-4 · DOI · Paper page
- Moore, 2006, The role of CCL12 in the recruitment of fibrocytes and lung fibrosis., Am. J. Respir. Cell Mol. Biol., 35, 175, 10.1165/rcmb.2005-0239OC · DOI · Paper page
- Muhanna, 2008, Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis., Hepatology, 48, 963, 10.1002/hep.22413 · DOI · Paper page
- Niedermeier, 2009, CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes., Proc. Natl. Acad. Sci. U.S.A., 106, 17892, 10.1073/pnas.0906070106 · DOI · Paper page
- Österreicher, 2011, Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver., Proc. Natl. Acad. Sci. U.S.A., 108, 308, 10.1073/pnas.1017547108 · DOI · Paper page
- Parola, 2008, Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario., Mol. Aspects Med., 29, 58, 10.1016/j.mam.2007.09.002 · DOI · Paper page
- Parsons, 2011, Mutation of the 5’-untranslated region stem-loop structure inhibits alpha1(I). collagen expression in vivo., J. Biol. Chem., 286, 8609, 10.1074/jbc.M110.189118 · DOI
- Pepke, 2009, Computation for ChIP-seq and RNA-seq studies., Nat. Methods, 6, S22, 10.1038/nmeth.1371 · DOI · Paper page
- Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis., J. Clin. Invest., 114, 438, 10.1172/JCI200420997 · DOI · Paper page
- Pilling, 2009, Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts., PLoS ONE, 4, 10.1371/journal.pone.0007475 · DOI · Paper page
- Pinzani, 2001, Cytokine receptors and signaling in hepatic stellate cells., Semin. Liver Dis., 21, 397, 10.1055/s-2001-17554 · DOI · Paper page
- Pope, 2005, Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation., J. Biol. Chem., 280, 13952, 10.1074/jbc.M406037200 · DOI · Paper page
- Quan, 2007, Culture and analysis of circulating fibrocytes., Methods Mol. Med., 135, 423, 10.1007/978-1-59745-401-8_28 · doi:10.1007/978-1-59745-401-8_28
- Quan, 2004, Circulating fibrocytes: collagen-secreting cells of the peripheral blood., Int. J. Biochem. Cell Biol., 36, 598, 10.1016/j.biocel.2003.10.005 · DOI · Paper page
- Reif, 2003, The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression., J. Biol. Chem., 278, 8083, 10.1074/jbc.M212927200 · DOI · Paper page
- Reilkoff, 2011, Fibrocytes: emerging effector cells in chronic inflammation., Nat. Rev. Immunol., 11, 427, 10.1038/nri2990 · DOI · Paper page
- Rinkevich, 2012, Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature., Nat. Cell Biol., 14, 1251, 10.1038/ncb2610 · DOI · Paper page
- Roderfeld, 2009, Bone marrow transplantation demonstrates medullar origin of CD34(+). fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-). mice., Hepatology, 51, 267, 10.1002/hep.23274 · DOI
- Russo, 2006, The bone marrow functionally contributes to liver fibrosis., Gastroenterology, 130, 1807, 10.1053/j.gastro.2006.01.036 · DOI · Paper page
- Sahebally, 2013, Circulating fibrocytes and Crohn’s disease., Br. J. Surg., 100, 1549, 10.1002/bjs.9302 · DOI
- Sakai, 2006, Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis., Proc. Natl. Acad. Sci. U.S.A., 103, 14098, 10.1073/pnas.0511200103 · DOI · Paper page
- Scholten, 2010, Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice., Gastroenterology, 139, 987, 10.1053/j.gastro.2010.05.005 · DOI · Paper page
- Scholten, 2011, Migration of fibrocytes in fibrogenic liver injury., Am. J. Pathol., 179, 189, 10.1016/j.ajpath.2011.03.049 · DOI
- Seki, 2009b, CCR2 promotes hepatic fibrosis in mice., Hepatology, 50, 185, 10.1002/hep.22952 · DOI · Paper page
- Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis., Nat. Med., 13, 1324, 10.1038/nm1663 · DOI · Paper page
- She, 2005, Adipogenic transcriptional regulation of hepatic stellate cells., J. Biol. Chem., 280, 4959, 10.1074/jbc.M410078200 · DOI · Paper page
- Shimamura, 2008, Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model., J. Immunol., 181, 4656, 10.4049/jimmunol.181.7.4656 · DOI · Paper page
- Stefanovic, 2003, 5’ stem-loop of collagen alpha 1(I). mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo., J. Biol. Chem., 278, 927, 10.1074/jbc.M209175200 · DOI · Paper page
- Stefanovic, 1997, Posttranscriptional regulation of collagen alpha1(I). mRNA in hepatic stellate cells., Mol. Cell. Biol., 17, 5201, 10.1128/MCB.17.9.5201 · DOI · Paper page
- Stefanovic, 2000, The 5’ stem-loop regulates expression of collagen alpha1(I). mRNA in mouse fibroblasts cultured in a three-dimensional matrix., Nucleic Acids Res., 28, 641, 10.1093/nar/28.2.641 · DOI
- Stefanovic, 2002, Inhibition of collagen alpha 1(I). expression by the 5’ stem-loop as a molecular decoy., J. Biol. Chem., 277, 18229, 10.1074/jbc.M108065200 · DOI · Paper page
- Stefanovic, 2005, Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils., Exp. Biol. Med., 230, 573, 10.1177/153537020523000809 · DOI · Paper page
- Strieter, 2007, The role of CXC chemokines in pulmonary fibrosis., J. Clin. Invest., 117, 549, 10.1172/JCI30562 · DOI · Paper page
- Strieter, 2009, The role of circulating mesenchymal progenitor cells (fibrocytes). in the pathogenesis of pulmonary fibrosis., J. Leukoc. Biol., 86, 1111, 10.1189/jlb.0309132 · DOI · Paper page
- Suzuki, 2008, p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver., Gastroenterology, 135, 270, 10.1053/j.gastro.2008.03.075 · DOI
- Taura, 2008, Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis., Gastroenterology, 135, 1729, 10.1053/j.gastro.2008.07.065 · DOI · Paper page
- Taura, 2010, Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice., Hepatology, 51, 1027, 10.1002/hep.23368 · DOI · Paper page
- Tsukamoto, 2005a, Adipogenic phenotype of hepatic stellate cells., Alcohol. Clin. Exp. Res., 29, 132S, 10.1097/01.alc.0000189279.92602.f0 · DOI
- Tsukamoto, 2005b, Fat paradox in liver disease., Keio J. Med., 54, 190, 10.2302/kjm.54.190 · DOI
- Tsukamoto, 2011, Epigenetic cell fate regulation of hepatic stellate cells., Hepatol. Res., 41, 675, 10.1111/j.1872-034X.2011.00804.x · DOI · Paper page
- Tsukamoto, 2012, Morphogens and hepatic stellate cell fate regulation in chronic liver disease., J. Gastroenterol. Hepatol., 94, 10.1111/j.1440-1746.2011.07022.x · DOI · Paper page
- Tuchweber, 1996, Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat., Lab. Invest., 74, 265
- Uchinami, 2006, Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis., Hepatology, 44, 420, 10.1002/hep.21268 · DOI · Paper page
- Uchio, 2002, Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts., Lab. Invest., 82, 619, 10.1038/labinvest.3780456 · DOI
- Venkataraman, 1999, Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex., Proc. Natl. Acad. Sci. U.S.A., 96, 3658, 10.1073/pnas.96.7.3658 · DOI · Paper page
- von Kockritz-Blickwede, 2008, Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation., Blood, 111, 3070, 10.1182/blood-2007-07-104018 · DOI · Paper page
- Wada, 2007, Fibrocytes: a new insight into kidney fibrosis., Kidney Int., 72, 269, 10.1038/sj.ki.5002325 · DOI
- Watsky, 2010, New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies., Int. Rev. Cell. Mol. Biol., 282, 165, 10.1016/S1937-6448(10)82004-0 · DOI
- Wells, 2008, The role of matrix stiffness in regulating cell behavior., Hepatology, 47, 1394, 10.1002/hep.22193 · DOI · Paper page
- Wells, 2014, The portal fibroblast: not just a poor man’s stellate cell., Gastroenterolog, 147, 41, 10.1053/j.gastro.2014.05.001 · DOI
- Wells, 2004, Autocrine release of TGF-beta by portal fibroblasts regulates cell growth., FEBS Lett., 559, 107, 10.1016/S0014-5793(04)00037-7 · DOI · Paper page
- Wen, 2012, Isolation of rat portal fibroblasts by in situ liver perfusion., J. Vis. Exp., 64
- Yang, 2008, Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers., Stem Cells, 26, 2104, 10.1634/stemcells.2008-0115 · DOI · Paper page
- Yang, 2012, Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect., Hepatology, 55, 1271, 10.1002/hep.24792 · DOI
- Yata, 2003, DNase I-hypersensitive sites enhance alpha1(I). collagen gene expression in hepatic stellate cells., Hepatology, 37, 267, 10.1053/jhep.2003.50067 · DOI · Paper page
- Yovchev, 2009, Thymus cell antigen-1-expressing cells in the oval cell compartment., Hepatology, 50, 601, 10.1002/hep.23012 · DOI
Cited by
Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions
Kennedy, P., Wagner, M., Castéra, L., Hong, C. W., Johnson, C. L., Sirlin, C. B., & Taouli, B. (2018) · Radiology · doi:10.1148/radiol.2018170601 · Cited by 271
Inflammasomes in liver fibrosis
Alegre, F., Pelegrin, P., & Feldstein, A. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1601350 · Cited by 176
Inzaugarat, M. E., Johnson, C. D., Holtmann, T. M., McGeough, M. D., Trautwein, C., Papouchado, B. G., Schwabe, R., Hoffman, H. M., Wree, A., & Feldstein, A. E. (2019) · Hepatology · doi:10.1002/hep.30252 · Cited by 148
“However, activated HSCs represent the fundamental fibrogenic cell type involved in this process independent of the etiology of liver damage.(9,18) Upon sustained liver damage, HSCs undergo an activation process that involves increased expression of TIMP-1, as well as ECM proteins such as collagens.”
BackgroundNagasaki, A., Sakamoto, S., Chea, C., Ishida, E., Furusho, H., Fujii, M., Takata, T., & Miyauchi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60904-8 · Cited by 82
Ferret-Miñana, A., Alcaraz, E., Horrillo, R., Ramón-Azcón, J., & De Chiara, F. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1798323
“Following damage, monocytes are recruited to the liver, differentiating into macrophages that secrete pro-inflammatory cytokines and chemokines (e.g., TNF-alpha, IL-1beta, TGF-beta) (Xu J, 2014).”
Influential
Metadata
- Authors
- Xu, J., Liu, X., Koyama, Y., Wang, P., Lan, T., Kim, I.-G., Kim, I. H., Ma, H.-Y., & Kisseleva, T.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2014-07-22
- Volume
- 5
- Pages
- 167-167
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2107036592
- Cited by
- 126
- References
- 23
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.